Unknown

Dataset Information

0

A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma.


ABSTRACT: Polo-like kinase 1 (PLK1) is highly expressed in group 3 medulloblastoma (MB), and it has been preclinically validated as a cancer therapeutic target in medulloblastoma. Here, we demonstrate that PLK1 inhibition with PCM-075 or BI6727 significantly reduces the growth of MB cells and causes a decrease of c-MYC mRNA and protein levels. We show that MYC activates PLK1 transcription, while the inhibition of PLK1 suppresses MB tumor development and causes a decrease in c-MYC protein level by suppressing FBXW7 auto poly-ubiquitination. FBXW7 physically interacts with PLK1 and c-MYC, facilitating their protein degradation by promoting ubiquitination. These results demonstrate a PLK1-FBXW7-MYC regulatory loop in MYC-driven medulloblastoma. Moreover, FBXW7 is significantly downregulated in group 3 patient samples. The overexpression of FBXW7 induced apoptosis and suppressed proliferation in vitro and in vivo, while constitutive phosphorylation mutation attenuated its tumor suppressor function. Altogether, these findings demonstrated that PLK1 inhibition stabilizes FBXW7 in MYC-driven MB, thus revealing an important function of FBXW7 in suppressing medulloblastoma progression.

SUBMITTER: Wang D 

PROVIDER: S-EPMC7865656 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma.

Wang Dong D   Pierce Angela A   Veo Bethany B   Fosmire Susan S   Danis Etienne E   Donson Andrew A   Venkataraman Sujatha S   Vibhakar Rajeev R  

Cancers 20210121 3


Polo-like kinase 1 (<i>PLK1</i>) is highly expressed in group 3 medulloblastoma (MB), and it has been preclinically validated as a cancer therapeutic target in medulloblastoma. Here, we demonstrate that PLK1 inhibition with PCM-075 or BI6727 significantly reduces the growth of MB cells and causes a decrease of <i>c-MYC</i> mRNA and protein levels. We show that MYC activates <i>PLK1</i> transcription, while the inhibition of PLK1 suppresses MB tumor development and causes a decrease in c-MYC prot  ...[more]

Similar Datasets

| S-EPMC8917408 | biostudies-literature
| S-EPMC3285431 | biostudies-literature
| S-EPMC5293723 | biostudies-literature
| S-EPMC6274763 | biostudies-literature
| S-EPMC5992137 | biostudies-literature
| S-EPMC5966365 | biostudies-literature
| S-EPMC5605674 | biostudies-literature
| S-EPMC7764474 | biostudies-literature
| S-EPMC7573506 | biostudies-literature
| S-EPMC5071541 | biostudies-literature